Endocrine Practice Journal
Overview
Publication venue for
- American Association of Clinical Endocrinology Consensus Statement: Comprehensive Type 2 Diabetes Management Algorithm-2023 Update. 29:305-340. 2023
- CONSENSUS STATEMENT BY THE AMERICAN ASSOCIATION OF CLINICAL ENDOCRINOLOGISTS AND AMERICAN COLLEGE OF ENDOCRINOLOGY ON THE COMPREHENSIVE TYPE 2 DIABETES MANAGEMENT ALGORITHM-2020 EXECUTIVE SUMMARY. 26:107-139. 2020
- CONSENSUS STATEMENT BY THE AMERICAN ASSOCIATION OF CLINICAL ENDOCRINOLOGISTS AND AMERICAN COLLEGE OF ENDOCRINOLOGY ON THE COMPREHENSIVE TYPE 2 DIABETES MANAGEMENT ALGORITHM-2019 EXECUTIVE SUMMARY. 25:69-100. 2019
- CONSENSUS STATEMENT BY THE AMERICAN ASSOCIATION OF CLINICAL ENDOCRINOLOGISTS AND AMERICAN COLLEGE OF ENDOCRINOLOGY ON THE COMPREHENSIVE TYPE 2 DIABETES MANAGEMENT ALGORITHM-2018 EXECUTIVE SUMMARY. 24:91-120. 2018
- GLUCAGON-LIKE PEPTIDE 1 RECEPTOR AGONISTS FOR TYPE 2 DIABETES: A COMPREHENSIVE REVIEW OF HOW TO WEIGH THE OPTIONS, SELECT THE RIGHT PATIENTS, AND MAXIMIZE BENEFITS. 24:8-22. 2018
- CONSENSUS STATEMENT BY THE AMERICAN ASSOCIATION OF CLINICAL ENDOCRINOLOGISTS AND AMERICAN COLLEGE OF ENDOCRINOLOGY ON THE COMPREHENSIVE TYPE 2 DIABETES MANAGEMENT ALGORITHM-2017 EXECUTIVE SUMMARY. 23:207-238. 2017
- NEWER LONG-ACTING BASAL INSULIN PREPARATIONS. 23:13-17. 2017
- CONSENSUS STATEMENT BY THE AMERICAN ASSOCIATION OF CLINICAL ENDOCRINOLOGISTS AND AMERICAN COLLEGE OF ENDOCRINOLOGY ON THE COMPREHENSIVE TYPE 2 DIABETES MANAGEMENT ALGORITHM-2016 EXECUTIVE SUMMARY. 22:84-102. 2016
- AMERICAN ASSOCIATION OF CLINICAL ENDOCRINOLOGISTS AND AMERICAN COLLEGE OF ENDOCRINOLOGY - CLINICAL PRACTICE GUIDELINES FOR DEVELOPING A DIABETES MELLITUS COMPREHENSIVE CARE PLAN-2015-EXECUTIVE SUMMARY. 21:413-437. 2015
- CONSENSUS STATEMENT BY THE AMERICAN ASSOCIATION OF CLINICAL ENDOCRINOLOGISTS AND AMERICAN COLLEGE OF ENDOCRINOLOGY ON THE COMPREHENSIVE TYPE 2 DIABETES MANAGEMENT ALGORITHM-2015 EXECUTIVE SUMMARY. 21:1403-1414. 2015
- FIXED-DOSE COMBINATION THERAPY IN TYPE 2 DIABETES MELLITUS. 20:1322-1332. 2014
- IDENTIFYING RISK FACTORS FOR SEVERE HYPOGLYCEMIA IN HOSPITALIZED PATIENTS WITH DIABETES. 20:1051-1056. 2014
- BONE MINERAL DENSITY IN PATIENTS WITH NONALCOHOLIC STEATOHEPATITIS AMONG END-STAGE LIVER DISEASE PATIENTS AWAITING LIVER TRANSPLANTATION. 19:414-419. 2013
- LIRAGLUTIDE ACHIEVES A1C TARGETS MORE OFTEN THAN SITAGLIPTIN OR EXENATIDE WHEN ADDED TO METFORMIN IN PATIENTS WITH TYPE 2 DIABETES AND A BASELINE A1C < 8.0%. 19:64-72. 2013
- THE ROLE OF BROMOCRIPTINE-QR IN THE MANAGEMENT OF TYPE 2 DIABETES EXPERT PANEL RECOMMENDATIONS. 19:100-106. 2013
- CURRENT ISSUES IN GLP-1 RECEPTOR AGONIST THERAPY FOR TYPE 2 DIABETES. 18:6-26. 2012
Identity
International Standard Serial Number (ISSN)
- 1530-891X